Sorry, you need to enable JavaScript to visit this website.

    Pfizer Declares First-Quarter 2013 Dividend

    Board of Directors approves increase in quarterly cash dividend to $0.24 per share

    "We remain focused on total return to shareholders, of which the dividend is a key component."

    (BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 24-cent first-quarter 2013 dividend on the company’s common stock, payable March 5, 2013, to shareholders of record at the close of business on February 1, 2013. Pfizer increased the dividend by approximately 9 percent, to 24 cents from 22 cents per share.

     

    The first-quarter 2013 cash dividend will be the 297th consecutive quarterly dividend paid by Pfizer.

    “The dividend increase is a testament to our continued commitment to returning capital to shareholders and demonstrates our continued confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer. “We remain focused on total return to shareholders, of which the dividend is a key component.”

    Pfizer Inc.
    Media
    Joan Campion, 212-733-2798
    or
    Investors
    Suzanne Harnett, 212-733-8009

    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now Details